MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 57 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,000 | +44.0% | 7,399 | +100.6% | 0.00% | – |
Q2 2023 | $25,000 | +47.1% | 3,688 | +68.8% | 0.00% | – |
Q1 2023 | $17,000 | -56.4% | 2,185 | -58.1% | 0.00% | – |
Q4 2022 | $39,000 | +457.1% | 5,215 | +514.3% | 0.00% | – |
Q3 2022 | $7,000 | 0.0% | 849 | +28.2% | 0.00% | – |
Q2 2022 | $7,000 | -78.1% | 662 | -70.9% | 0.00% | – |
Q1 2022 | $32,000 | -52.9% | 2,275 | -32.2% | 0.00% | – |
Q4 2021 | $68,000 | +134.5% | 3,355 | +162.3% | 0.00% | – |
Q3 2021 | $29,000 | – | 1,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |